Gilles Favre
@GillesFavrecrct
Followers
169
Following
658
Statuses
422
Directeur du Centre de Recherches en Cancérologie de Toulouse
Joined August 2020
RT @VeraPancaldi: Abstracts closing 10 Oct! 5-7 February for clinicians and researchers, AI session with @FertigLab…
0
6
0
RT @CHUdeToulouse: Félicitations au Pr Elie Serrano, pour sa #nomination en tant que chef du pôle des voies respiratoires du CHU de Toulous…
0
3
0
RT @crctoncopole: Programmation génétique : les travaux de recherche de Sylvain Cussat-Blanc de @IRIToulouse et Salvatore Valitutti @Valit…
0
7
0
RT @psharmalab: Thrilled with #Embocitrullnation success @MAChristoLab thank you all the participants 🤗 Grand merci @IpbsToulouse @Isabel…
0
5
0
RT @ToulouseCancer: ✨ Il est arrivé ! ✨ Nous sommes ravis d'annoncer que notre rapport d'activité pour l'année 2022-2023 est désormais dis…
0
1
0
RT @ToulouseCancer: 📸 Retour en image sur la soirée de clôture Ride, Row & Run : À la fin du challenge, nous avons eu l’occasion de nous ré…
0
1
0
RT @oncodaily: TT-derived drug-tolerant (DT) lung cancer cells are vulnerable to FTIs - @ocalvayrac
@NatureComms
0
5
0
RT @CNRSbiologie: #ResultatScientifique 🔎 | Cancer du poumon: une nouvelle piste pour combattre les résistances aux thérapies ciblées 🤝 @…
0
6
0
RT @crctoncopole: 🇬🇧Prevention of resistances to targeted therapies in lung cancer with a new therapeutic combination. New article publishe…
0
6
0
RT @GillesFavrecrct: Very proud to share with you our latest work published in Nature Communications which highlights the critical role of…
0
4
0
RT @TonyLemarie: Very nice study by @ocalvayrac and @GillesFavrecrct at @SIGNATHER and @crctoncopole. Well done!
0
1
0
RT @ocalvayrac: We obviously aimed to block this pathway using a panel of inhibitors. Although most of them interfered with the adaptive re…
0
2
0
RT @ocalvayrac: We next focused on the “muscle” part of the phenotype, and we observed a highly reorganized actin cytoskeleton in all the m…
0
2
0
RT @ocalvayrac: We used these transcriptomic data to build 2 signatures of drug-tolerance: 212 commonly upregulated and 495 downregulated g…
0
3
0
RT @ocalvayrac: Among almost 30,000 Human Molecular Signatures Database (MSigDB) gene sets tested, AT1 was one of the only 3 signatures tha…
0
2
0
RT @ocalvayrac: We observed a deep lineage reprogramming involving the emergence of an alveolar-type 1 (AT1) phenotype restricted to G1-arr…
0
2
0
RT @ocalvayrac: Thrilled & proud to be part of this fantastic #COALA network! Looking forward to great scientific discussions, sharing idea…
0
3
0
RT @ocalvayrac: Last but not least: an enormous thanks to all the people involved in this work, especially the first authors @FigarolSarah…
0
2
0